BE878011Q - LONG-TERM XANTHINE-BASED BRONCHO-DILATORS AND ANTI-ALLERGIC AGENTS - Google Patents
LONG-TERM XANTHINE-BASED BRONCHO-DILATORS AND ANTI-ALLERGIC AGENTSInfo
- Publication number
- BE878011Q BE878011Q BE0/196551A BE196551A BE878011Q BE 878011 Q BE878011 Q BE 878011Q BE 0/196551 A BE0/196551 A BE 0/196551A BE 196551 A BE196551 A BE 196551A BE 878011 Q BE878011 Q BE 878011Q
- Authority
- BE
- Belgium
- Prior art keywords
- broncho
- dilators
- xanthine
- term
- long
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/672,437 US4089959A (en) | 1976-03-31 | 1976-03-31 | Long-acting xanthine bronchodilators and antiallergy agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE878011Q true BE878011Q (en) | 1979-12-03 |
Family
ID=24698546
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE0/196551A BE878011Q (en) | 1976-03-31 | 1979-08-01 | LONG-TERM XANTHINE-BASED BRONCHO-DILATORS AND ANTI-ALLERGIC AGENTS |
Country Status (2)
| Country | Link |
|---|---|
| US (1) | US4089959A (en) |
| BE (1) | BE878011Q (en) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4207321A (en) * | 1977-04-02 | 1980-06-10 | Hoechst Aktiengesellschaft | Pharmaceutical compositions containing xanthines |
| SE7810946L (en) * | 1978-10-20 | 1980-04-21 | Draco Ab | METHOD OF TREATING CHRONIC OBSTRUCTIVE AIR DISEASE |
| SE7810947L (en) * | 1978-10-20 | 1980-04-21 | Draco Ab | 3-ALKYLXANTHINES |
| SE8002910L (en) * | 1980-04-18 | 1981-10-19 | Draco Ab | 3,8-DIALKYLXANTINES, PROCEDURES FOR THEIR PREPARATION, PREPARATION AND METHODS OF TREATMENT OF CHRONIC OBSTRUCTIVE AIR DISORDER AND CARDIOVASCULAR DISEASES |
| CH643260A5 (en) * | 1980-05-02 | 1984-05-30 | Nestle Sa | 1-ALLYL-3-BUTYL-8-METHYLXANTHINE, METHOD OF PREPARATION AND USE IN A MEDICAMENT. |
| US4636507A (en) * | 1984-04-30 | 1987-01-13 | Hoechst-Roussel Pharmaceuticals Inc. | Host defense mechanism enhancement |
| US4698144A (en) * | 1986-05-15 | 1987-10-06 | The Dow Chemical Company | Apparatus for balancing electrolytic cell gas with circulating electrolyte |
| US4772607A (en) * | 1986-05-20 | 1988-09-20 | Warner-Lambert Company | Dialkenyl derivatives of xanthine, pharmaceutical compositions and methods of use therefor |
| US4755517A (en) * | 1986-07-31 | 1988-07-05 | Warner-Lambert Company | Derivatives of xanthine, pharmaceutical compositions and methods of use therefor |
| US5032593A (en) * | 1988-07-01 | 1991-07-16 | Marion Merrell Dow Inc. | Method of treating bronchoconstriction with 1,3-unsymmetrical straight chain alkyl-substituted 8-phenylxanthines |
| US5321029A (en) * | 1988-11-14 | 1994-06-14 | Beecham-Wuelfing Gmbh & Co.K.G. | Xanthines |
| US5658881A (en) * | 1994-10-14 | 1997-08-19 | Twk, Inc. | Method for topical inhibition of the metabolic activity of cytochrome P450 |
| US5981549A (en) * | 1997-02-14 | 1999-11-09 | Synapse Pharmaceutical International | Method for controlling or alleviating the symptoms of respiratory disease and allergies |
| US6403567B1 (en) * | 1999-06-22 | 2002-06-11 | Cv Therapeutics, Inc. | N-pyrazole A2A adenosine receptor agonists |
| USRE47351E1 (en) | 1999-06-22 | 2019-04-16 | Gilead Sciences, Inc. | 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists |
| US6815446B1 (en) | 1999-08-31 | 2004-11-09 | Vanderbilt University | Selective antagonists of A2B adenosine receptors |
| US6281248B1 (en) | 2000-02-16 | 2001-08-28 | Magda Abdel Fattah Ahmed | Composition for treating asthma |
| US20020012946A1 (en) * | 2000-02-23 | 2002-01-31 | Luiz Belardinelli | Method of identifying partial agonists of the A2A receptor |
| US8470801B2 (en) | 2002-07-29 | 2013-06-25 | Gilead Sciences, Inc. | Myocardial perfusion imaging methods and compositions |
| US20050020915A1 (en) * | 2002-07-29 | 2005-01-27 | Cv Therapeutics, Inc. | Myocardial perfusion imaging methods and compositions |
| JP2005538190A (en) * | 2002-07-29 | 2005-12-15 | シーブイ・セラピューティクス・インコーポレイテッド | Myocardial perfusion imaging |
| US7655636B2 (en) | 2004-10-20 | 2010-02-02 | Gilead Palo Alto, Inc. | Use of A2A adenosine receptor agonists |
| US8262578B1 (en) | 2004-11-24 | 2012-09-11 | Pacesetter, Inc. | System and method for detecting physiologic states based on intracardiac electrogram signals while distinguishing cardiac rhythm types |
| US7361146B1 (en) | 2004-11-24 | 2008-04-22 | Pacesetter, Inc. | System and method for detecting abnormal respiration via respiratory parameters derived from intracardiac electrogram signals |
| US7435221B1 (en) | 2004-11-24 | 2008-10-14 | Pacesetter, Inc. | System and method for detecting abnormal respiration based on intracardiac electrogram signals using a pattern recognition device |
| US7404799B1 (en) | 2005-04-05 | 2008-07-29 | Pacesetter, Inc. | System and method for detection of respiration patterns via integration of intracardiac electrogram signals |
| US20070049757A1 (en) * | 2005-08-26 | 2007-03-01 | Rieger Jayson M | Methods for the synthesis of substituted amino uracils |
| US7732595B2 (en) * | 2006-02-03 | 2010-06-08 | Gilead Palo Alto, Inc. | Process for preparing an A2A-adenosine receptor agonist and its polymorphs |
| US20090081120A1 (en) * | 2006-09-01 | 2009-03-26 | Cv Therapeutics, Inc. | Methods and Compositions for Increasing Patient Tolerability During Myocardial Imaging Methods |
| CA2662278C (en) * | 2006-09-01 | 2011-11-22 | Cv Therapeutics, Inc. | Methods and compositions for increasing patient tolerability during myocardial imaging methods |
| JP2011502101A (en) * | 2006-09-29 | 2011-01-20 | ギリアード・パロ・アルト・インコーポレイテッド | Myocardial imaging in patients with a history of lung disease |
| JP2010515081A (en) * | 2007-01-03 | 2010-05-06 | ギリアード・パロ・アルト・インコーポレイテッド | Myocardial perfusion imaging |
| MX2011003168A (en) * | 2008-09-29 | 2011-05-19 | Gilead Sciences Inc | Combinations of a rate control agent and an a-2-alpha receptor antagonist for use in multidetector computed tomography methods. |
| JP2012521411A (en) * | 2009-03-26 | 2012-09-13 | マピ ファーマ リミテッド | Alogliptin preparation process |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2729643A (en) * | 1956-01-03 | J-disubstmjied and i | ||
| DE1911279A1 (en) * | 1969-03-05 | 1970-11-12 | Eckert Dr Theodor | Process to increase the ability of drugs to be absorbed |
| US3624216A (en) * | 1970-06-25 | 1971-11-30 | Abbott Lab | 8-substituted theophyllines as anti-inflammatory agents |
| US3624215A (en) * | 1970-06-25 | 1971-11-30 | Abbott Lab | 8-substituted theophyllines as anti-anxiety agents |
-
1976
- 1976-03-31 US US05/672,437 patent/US4089959A/en not_active Expired - Lifetime
-
1979
- 1979-08-01 BE BE0/196551A patent/BE878011Q/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US4089959A (en) | 1978-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE878011Q (en) | LONG-TERM XANTHINE-BASED BRONCHO-DILATORS AND ANTI-ALLERGIC AGENTS | |
| NO148832C (en) | AUTOMATIC MEASURING AND DELIVERY DEVICE | |
| JPS5349545A (en) | Model device | |
| BE852737A (en) | QUINOXALINONES AND QUINOXALINES | |
| BE851941A (en) | VERSTERKINGSSCHERMEN VOOR GEBRUIK IN DE RONTGENFOTOGRAFIE | |
| SE7512799L (en) | SUSPENSION AND STORAGE DEVICE | |
| PL202070A1 (en) | REGAL AND REGALOW | |
| JPS52148061A (en) | 66carboxymethyl thiocortisol and derivatives thereof | |
| BE850490A (en) | TRINCORIAL COMPOSITIONS BASED ON DIPHENYL-AMINES AND POLYPHYDROXYBENZENES | |
| SE7712707L (en) | PENDANT DEVICE | |
| SE427802B (en) | PLAY AND OVENING DEVICE | |
| JPS5312007A (en) | Bearing device | |
| NO773297L (en) | DRAWING AND SUSPENSION DEVICE. | |
| GB1546126A (en) | Artificial legs | |
| BE858172A (en) | TEA-BASED COMPOSITIONS AND THEIR PREPARATION | |
| JPS52108979A (en) | 33substitutedd55phenyll55pyridylhydantoin and antiiarrhythmic agents | |
| JPS52142829A (en) | Moving form construction and form device used therefor | |
| JPS53356A (en) | Bearing device | |
| SE7713045L (en) | LUNNINGS AND BUNTNINGSLEPKERRA | |
| SE7601727L (en) | BASIC AND HOLE ELEMENTS | |
| BE860110A (en) | ANTI-COCCIDIANS AND OVO-LARVICIDES CONTAINING AN AMINO-ALKANE | |
| JPS53355A (en) | Bearing device | |
| JPS5365542A (en) | Bearing device | |
| JPS538447A (en) | Bearing device | |
| JPS52135952A (en) | Bearing device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: BERLEX LABORATORIES INC. Effective date: 19960831 |